Ozempic 与 Mounjaro 减重计算器 (2026)
临床试验基准，非结果保证
根据已发表的临床试验平均数据，估算使用 Ozempic、Wegovy 和 Mounjaro 的减重基准。
已发表的临床试验基准
A realistic weight-loss goal has three parts: how much, how fast, and how you will hold the deficit. For most people a 5–10% loss is a strong first target and already improves blood pressure, blood sugar, and cholesterol.
Weight loss comes from an energy deficit — roughly 7700 kcal under maintenance per kilogram of fat (about 3500 kcal per pound). A daily deficit of 250–1000 kcal gives a sustainable 0.25–0.9 kg (about 0.5–2 lb) per week. GLP-1 medications such as semaglutide and tirzepatide mainly help by lowering appetite, which makes that deficit easier to keep.
如何解读结果
| Daily calorie deficit | Weekly weight loss |
|---|---|
| 250 kcal/day | ~0.25 kg (0.5 lb)Best |
| 500 kcal/day | ~0.45 kg (1 lb) |
| 750 kcal/day | ~0.7 kg (1.5 lb) |
| 1000 kcal/day | ~0.9 kg (2 lb) |
如何使用此计算器
| Medication | Avg. total weight loss | Trial duration (weeks) |
|---|---|---|
| Liraglutide (Saxenda) | ~8% | 56Best |
| Semaglutide 2.4 mg (Wegovy) | ~15% | 68 |
| Tirzepatide 15 mg (Zepbound) | ~21% | 72 |
| Retatrutide 12 mg (phase 2) | ~24% | 48 |
如何有效利用此计算器
How to read these numbers safely
The medication percentages are population averages from clinical trials at the top maintenance dose; your result can be higher or lower depending on dose, adherence, diet, activity, and physiology. Use them to set expectations, not as a promise.
Aim for steady, sustainable loss rather than the fastest possible; keep protein, fluids, and sleep adequate, and bring your weight log and medication history to your clinician instead of self-escalating the dose. This tool is for planning, not medical advice.
常见问题
它根据已发表的临床试验平均数据，为您估算使用 Ozempic、Wegovy 和 Mounjaro 的减重参考基准。
可以。Shotlee 支持追踪剂量、副作用和各项健康指标。该应用是免费的。
作为临床试验基准参考，该计算器是准确的，但个体差异很大。请将其作为规划工具，而非结果保证。
在调整剂量后，或者当您的体重发生显著变化导致之前的基准对比失去参考价值时，请重新计算。
在 Shotlee 中追踪您的减重趋势
免费的剂量记录、副作用追踪和健康指标监测，为您提供完整的方案管理。